Chemoinformaics analysis of 9,10-DIMETHOXYPTEROCARPAN-3-O-BETA-D-GLUCOSIDE
| Molecular Weight | 462.451 | nRot | 5 |
| Heavy Atom Molecular Weight | 436.243 | nRig | 26 |
| Exact Molecular Weight | 462.153 | nRing | 5 |
| Solubility: LogS | -3.735 | nHRing | 3 |
| Solubility: LogP | 0.488 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 2 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 12 |
| nHA | 10 | APOL | 63.7666 |
| nHD | 4 | BPOL | 36.4994 |
| QED | 0.497 |
| Synth | 4.236 |
| Natural Product Likeliness | 2.226 |
| NR-PPAR-gamma | 0.038 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.253 |
| HIA | 0.041 |
| CACO-2 | -5.858 |
| MDCK | 0.0000408 |
| BBB | 0.394 |
| PPB | 0.829397 |
| VDSS | 0.499 |
| FU | 0.143691 |
| CYP1A2-inh | 0.016 |
| CYP1A2-sub | 0.586 |
| CYP2c19-inh | 0.018 |
| CYP2c19-sub | 0.9 |
| CYP2c9-inh | 0.006 |
| CYP2c9-sub | 0.571 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.661 |
| CYP3a4-inh | 0.045 |
| CYP3a4-sub | 0.647 |
| CL | 3.583 |
| T12 | 0.097 |
| hERG | 0.093 |
| Ames | 0.484 |
| ROA | 0.109 |
| SkinSen | 0.087 |
| Carcinogencity | 0.839 |
| EI | 0.006 |
| Respiratory | 0.029 |
| NR-Aromatase | 0.845 |
| Antiviral | Yes |
| Prediction | 0.969431 |